Body temperature drives azole tolerance in Candida albicans by hindering the autophagic degradation of Erg11

This study reveals that human body temperature (37°C) enhances azole tolerance in *Candida albicans* by inducing mitochondrial dysfunction and reactive oxygen species accumulation, which inhibits autophagy-mediated degradation of the drug target Erg11, thereby preserving its levels and reducing antifungal efficacy.

The Gist

The Big Picture: Why Fever Makes Fungal Infections Harder to Treat

Imagine your body is a fortress, and a fungus called Candida albicans is an invader trying to break in. Doctors usually fight this invader with a specific type of weapon called azoles (a common antifungal drug). These drugs work by targeting a specific machine inside the fungus called Erg11. If you break this machine, the fungus can't build its protective armor (ergosterol) and it dies.

However, doctors have noticed a frustrating problem: these drugs often work better in a petri dish at room temperature (30°C) than they do inside a human body at fever temperature (37°C). Even if the fungus isn't "resistant" (meaning it hasn't mutated to ignore the drug), the drug just doesn't kill it as effectively when the body is hot.

This study asks: Why does the heat make the fungus tougher?

The Discovery: The "Recycling Plant" Gets Clogged

To understand the answer, we need to look at how the fungus manages its machinery.

1. The Normal Routine (30°C):
   Think of the Erg11 machine as a piece of equipment that gets worn out over time. In a cool environment (like a petri dish), the fungus has a very efficient recycling plant (called autophagy). When Erg11 gets old or damaged, the recycling plant grabs it, breaks it down, and throws it away. This keeps the supply of Erg11 machines at a healthy, manageable level. When you add the drug, it breaks the few machines that are left, and the fungus dies.

2. The Heat Stress (37°C):
   When the fungus enters a human body (or a feverish one), the temperature rises to 37°C. This heat acts like a power outage for the fungus's recycling plant.

   • The heat causes the fungus's power generators (mitochondria) to sputter and produce toxic fumes called ROS (Reactive Oxygen Species).
   • Because of this toxic fume, the recycling plant gets confused. Instead of going to the "trash bin" (the vacuole) to clean up old Erg11 machines, the plant's workers (proteins like Atg8) run over to the power generators to try and fix the damage.
   • Result: The recycling plant stops working. The old, worn-out Erg11 machines pile up because they aren't being thrown away.

The Consequence: Too Many Machines, Too Much Drug Resistance

Because the recycling plant is broken, the fungus ends up with a massive stockpile of Erg11 machines.

• The Drug's Dilemma: The antifungal drug (azole) is like a hammer trying to smash these machines.
• The Fungus's Advantage: Since the heat stopped the fungus from throwing away the old machines, there are now too many machines for the drug to destroy. The drug smashes a few, but the pile is so huge that the fungus can still build its armor and survive.

It's not that the fungus learned a new trick to ignore the hammer; it's that the heat simply refused to throw away the old hammers, leaving the fungus with an endless supply of targets to keep working.

The "Aha!" Moment: Fixing the Recycling Plant

The researchers tested a theory: What if we could clear the toxic fumes (ROS) caused by the heat?

They added an antioxidant (a chemical that neutralizes toxic fumes) to the mix.

• What happened? The power generators stopped sputtering. The toxic fumes cleared up.
• The Result: The recycling plant woke up! It went back to work, grabbed the pile of old Erg11 machines, and threw them away.
• The Outcome: With the stockpile gone, the antifungal drug could finally do its job and kill the fungus, even at body temperature.

Summary Analogy: The Factory and the Fire

Imagine a factory (the fungus) making cars (armor) using a specific robot arm (Erg11).

• The Drug is a saboteur trying to break the robot arms.
• The Recycling Plant is the team that throws away broken robot arms so the factory doesn't get cluttered.
• Body Heat is like a fire starting in the factory's power room.
• The Problem: The fire creates smoke (ROS). The recycling team gets distracted by the smoke and stops throwing away the broken robot arms. The factory floor gets piled high with spare robot arms.
• The Saboteur's Failure: The saboteur breaks a few arms, but there are so many spares piled up that the factory keeps running.
• The Solution: If you put out the fire (using antioxidants), the recycling team goes back to work, clears the pile, and the saboteur can finally shut the factory down.

Why This Matters

This study explains why antifungal drugs sometimes fail in humans even when the bacteria aren't "super-resistant." It's because our own body heat accidentally helps the fungus by clogging its trash disposal system.

The good news? This suggests a new way to treat infections. If we combine standard antifungal drugs with medicines that help the fungus's recycling system work better (or clear the toxic fumes), we might be able to make these drugs much more effective against fungal infections in humans.

Technical Summary

Title

Body temperature drives azole tolerance in Candida albicans by hindering the autophagic degradation of Erg11

1. Problem Statement

• Clinical Challenge: While Candida albicans azole resistance (genetic mutations leading to increased MIC) is relatively low (<1%), clinical treatment failures are common. A major contributor is azole tolerance, where the fungus survives and proliferates at drug concentrations above the Minimum Inhibitory Concentration (MIC) without a change in the MIC itself.
• The Gap: It is known that human body temperature (37°C) reduces the efficacy of azoles compared to standard laboratory temperatures (30°C). However, the precise molecular mechanisms by which short-term exposure to 37°C induces this tolerance in non-resistant strains remain unclear.
• Objective: To elucidate the mechanism by which physiological temperature (37°C) enhances azole tolerance in C. albicans and identify potential therapeutic targets to restore drug efficacy.

2. Methodology

The study employed a multidisciplinary approach combining microbiology, molecular genetics, biochemistry, and transcriptomics:

• Phenotypic Assays:
  • MIC and SMG Measurement: Determined Minimum Inhibitory Concentration (MIC) and Super-MIC Growth (SMG) to distinguish between resistance and tolerance in wild-type and mutant strains at 30°C vs. 37°C.
  • In Vivo Model: Used Galleria mellonella (wax moth larvae) infected with C. albicans to assess survival rates under FLC treatment at different temperatures.
  • Drug Combinations: Tested synergistic effects of azoles with autophagy inhibitors (wortmannin), proteasome inhibitors (MG132), and ROS scavengers (DPI).
• Genetic Manipulation:
  • Constructed homozygous null mutants for key genes: ERG11, ATG8, UPC2, CDR1, and various ergosterol pathway genes (ERG2, 4, 6, 9, 11, 24, 26, 27).
  • Created Tet-off inducible strains to regulate ERG11 expression.
  • Generated GFP-tagged strains (Erg11-GFP, Upc2-GFP, Atg8-GFP) for localization studies.
• Protein Dynamics & Localization:
  • Cycloheximide (CHX) Chase: Measured protein degradation rates of Erg11-GFP at different temperatures.
  • Western Blotting: Analyzed protein levels and autophagic flux (GFP-Atg8 cleavage).
  • Confocal Microscopy: Visualized co-localization of Erg11 with vacuoles, and Atg8 with mitochondria and Endoplasmic Reticulum (ER) using specific dyes (CellTracker Blue, MitoTracker, ER-Tracker).
• Omics & Metabolomics:
  • RNA-seq & GSEA: Performed transcriptomic analysis to identify differentially expressed genes (DEGs) and pathway enrichment (TCA cycle, oxidative phosphorylation, ROS response) between 30°C and 37°C.
  • GC-MS: Quantified intracellular sterol levels (ergosterol, lanosterol, etc.).
  • ROS & Mitochondrial Assays: Measured Reactive Oxygen Species (ROS) using DCFH-DA and Mitochondrial Membrane Potential (MMP) using JC-1 flow cytometry.

3. Key Contributions & Results

A. Temperature-Induced Tolerance is Erg11-Dependent

• Exposure to 37°C significantly increased the SMG (tolerance) of C. albicans to fluconazole (FLC) and other azoles, as well as other ergosterol biosynthesis inhibitors (terbinafine, fluvastatin), but did not alter the MIC (resistance).
• This tolerance was observed across multiple Candida species and was reversed by the calcineurin inhibitor cyclosporin A.
• The tolerance mechanism relies specifically on Erg11 (the azole target). Overexpression of ERG11 rescued growth under FLC at 37°C, while deletion of downstream genes (ERG24) did not abolish tolerance.

B. Mechanism: Inhibition of Erg11 Degradation via Autophagy

• Degradation Rate: CHX chase assays revealed that Erg11 has a shorter half-life at 30°C (0.93 h) compared to 37°C (1.65 h).
• Pathway Identification:
  • The autophagy inhibitor wortmannin mimicked the 37°C effect (increased tolerance, reduced Erg11 degradation).
  • The proteasome inhibitor MG132 did not affect Erg11 degradation.
  • Deletion of the core autophagy gene ATG8 abolished Erg11 degradation and increased FLC tolerance even at 30°C.
  • Confocal microscopy confirmed Erg11 localizes to vacuoles (autophagic degradation) at 30°C, but this translocation is blocked at 37°C.
• Conclusion: Erg11 is degraded via the autophagy pathway (specifically ATG8-dependent), and body temperature inhibits this process, leading to Erg11 accumulation and increased tolerance.

C. The Upstream Trigger: Mitochondrial ROS and Stress

• Transcriptomics: RNA-seq at 37°C showed downregulation of mitochondrial energy metabolism (TCA cycle, oxidative phosphorylation) and upregulation of sulfur metabolism (antioxidant defense).
• ROS Accumulation: 37°C induced a significant increase in mitochondrial ROS levels compared to 30°C.
• ROS Scavenging: Treating cells with the ROS scavenger DPI at 37°C restored autophagic activity, accelerated Erg11 degradation, and reduced FLC tolerance.
• Atg8 Redistribution: Under heat stress (37°C), Atg8 protein accumulates around mitochondria (likely to manage mitochondrial damage) and is depleted from the ER. Since ER-localized Atg8 is required for standard autophagy, this redistribution inhibits the autophagic degradation of ER-resident proteins like Erg11.
• Genetic Evidence: The atg8Δ/Δ mutant showed reduced growth and higher mitochondrial dysfunction at 37°C compared to wild-type, suggesting Atg8 plays a protective role against heat-induced mitochondrial stress, but at the cost of inhibiting Erg11 turnover.

4. Significance and Implications

• Novel Mechanism of Tolerance: The study identifies a non-genetic, temperature-dependent mechanism of azole tolerance driven by the suppression of autophagy. It challenges the view that tolerance is solely a result of efflux pumps or transcriptional upregulation.
• Clinical Relevance: It explains why azole therapies often fail in vivo (at 37°C) even against "susceptible" strains. The human host environment itself acts as a stressor that inadvertently protects the fungus by stabilizing its drug target.
• Therapeutic Strategy: The findings suggest that promoting the degradation of Erg11 (e.g., by inducing autophagy or scavenging mitochondrial ROS) could be a viable adjuvant strategy to enhance the fungicidal efficacy of azoles in human hosts.
• Broader Impact: This work highlights the critical interplay between host environmental factors (temperature), organelle stress (mitochondria), and cellular quality control systems (autophagy) in fungal pathogenesis and drug resistance.

Summary Diagram Logic (Figure 8 in paper)

1. Heat Stress (37°C) $\rightarrow$ Mitochondrial Dysfunction $\rightarrow$ Increased ROS.
2. ROS Response $\rightarrow$ Atg8 proteins redistribute from ER to Mitochondria.
3. Result $\rightarrow$ Reduced ER-autophagy $\rightarrow$ Erg11 is not degraded.
4. Outcome $\rightarrow$ High Erg11 levels $\rightarrow$ Azole Tolerance.
5. Intervention $\rightarrow$ ROS scavengers or Autophagy inducers $\rightarrow$ Restore Erg11 degradation $\rightarrow$ Restore Azole Efficacy.